weight-loss drugs

SKC Inc., a South Korean chemical materials company under SK Group, is seeking to buy semiconductor and rechargeable battery materials companies in ...

South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...

Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...

Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US,  has applied to the Australian clini...

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...

South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...

SK Hynix Inc., the world’s second-largest memory chipmaker, said on Wednesday it will significantly slash its investment for this year after p...

LG Electronics Inc., the world’s leading home appliance maker, aims to take profit from the electric vehicle powertrain and car lighting units...

South Korea's National Pension Service (NPS), the world's third-largest pension fund, ranked 10th out of the global 42 state-owned investors by rate...

South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...

Samsung Electronics Co., the world’s largest memory chipmaker, is considering slashing its semiconductor production as the company is heading ...

South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...

South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...

ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...

GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...

Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...

South Korea's Eugene Investment & Securities on Monday cut S-Oil Corp.'s target share price from 140,000 won ($113.5) to 133,000 won due to a lo...

A new engineering plastic made of the compound material LUCON TX5007 and developed by South Korea's LG Chem Ltd. has been applied to the front fende...

Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...

South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...

South Korea's derivatives-linked securities that entered the knock-in or loss period due to stock slumps at home and abroad exceeded 1 trillion won ...

Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...

Toughened COVID-19 testing requirements on Chinese travelers will likely dent hopes for South Korea's low-cost airlines to recover from three years ...

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...

South Korean private equity firm Align Partners Capital Management Inc. is set to lead shareholder activism against the country’s top financia...

South Korea’s National Pension Service (NPS), the world’s third-largest such fund, is poised to report an annual loss in 2022 for the fi...